Cleared Traditional

K163099 - My Dose Coach

K163099 is an FDA 510(k) clearance for My Dose Coach, manufactured by Sanofi, Inc.. The device is a Class 2 General Hospital device with product code NDC cleared through the Traditional 510(k) pathway after a 135-day FDA review.

K163099 · Sanofi, Inc. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2017
Decision
135d
Days
Class 2
Risk

K163099 is an FDA 510(k) clearance for the My Dose Coach. Classified as Calculator, Drug Dose (product code NDC), Class II - Special Controls.

Submitted by Sanofi, Inc. (Cambridge, US). The FDA issued a Cleared decision on March 22, 2017 after a review of 135 days - within the typical 510(k) review window.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 868.1890 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Sanofi, Inc. devices

FDA 510(k) Submission Details - K163099

510(k) Number K163099 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 07, 2016
Decision Date March 22, 2017
Days to Decision 135 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
6d slower than avg
Panel avg: 129d · This submission: 135d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

NDC Device Classification - Class 2, Special Controls

Product Code NDC Calculator, Drug Dose
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.1890
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - NDC Calculator, Drug Dose

All 25
Devices cleared under the same product code (NDC) and FDA review panel - the closest regulatory comparables to K163099.
EndoTool SubQ
K180366 · Al Pacheco and Associates · Sep 2018
InPen Dose Calculator
K181327 · Companion Medical, Inc. · Jul 2018
Glooko Mobile Insulin Dosing System
K171450 · Glooko, Inc. · Feb 2018
ACCU-CHEK ADVISOR INSULIN GUIDANCE SOFTWARE
K043529 · Roche Diagnostics Corp. · Apr 2005
ABBOTT PHARAMACOKINETICS SYSTEMS
K851573 · Abbott Laboratories · Jan 1986